Herceptin-conjugated liposomes co-loaded with doxorubicin and simvastatin in targeted prostate cancer therapy.

Li, Ning; Xie, Xi; Hu, Yixuan; He, Huadong; Fu, Xian; Fang, Tiantian; Li, Changjiu

Li, Ning; Xie, Xi; Hu, Yixuan; He, Huadong; Fu, Xian; Fang, Tiantian; Li, Changjiu.

Afiliação

Li N; Department of Urology, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University Hangzhou 310006, China.
Xie X; Nanjing Medical University Nanjing 211166, China.
Hu Y; Department of Urology, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University Hangzhou 310006, China.
He H; Department of Urology, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University Hangzhou 310006, China.
Fu X; Nanjing Medical University Nanjing 211166, China.
Fang T; Department of Urology, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University Hangzhou 310006, China.
Li C; Department of Urology, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University Hangzhou 310006, China.

Am J Transl Res ; 11(3): 1255-1269, 2019.

Article em En | MEDLINE | ID: mdl-30972160

Palavras-chave

HER-2; Prostate cancer; doxorubicin; liposome; simvastatin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Transl Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google